Sg Americas Securities, LLC Citius Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$0.6 - $0.9 $13,228 - $19,843	-22,048 Reduced 34.96%	41,020 $37,000
Q4 2023 Jan 12, 2024	BUY	$0.65 - $0.86 $3,545 - $4,690	5,454 Added 9.47%	63,068 $48,000
Q3 2023 Oct 13, 2023	BUY	$0.65 - $1.25 $37,449 - $72,017	57,614 New	57,614 $39,000
Q3 2022 Oct 31, 2022	BUY	$0.14 - $1.33 $12,527 - $119,015	89,485 New	89,485 $108,000
Q2 2022 Jul 29, 2022	SELL	$0.88 - $1.87 $12,331 - $26,204	-14,013 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$1.38 - $1.89 $21,340 - $29,226	-15,464 Reduced 52.46%	14,013 $25,000
Q4 2021 Feb 07, 2022	SELL	$1.51 - $2.2 $66,174 - $96,412	-43,824 Reduced 59.79%	29,477 $45,000
Q3 2021 Nov 01, 2021	BUY	$1.74 - $2.6 $127,543 - $190,582	73,301 New	73,301 $149,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.